Study details
Enrolling now
Sentinel Cerebral Protection Device in Atrial Fibrillation Ablation Trial
Malini Madhavan
NCT IDNCT04685317ClinicalTrials.gov data as of Apr 2026
Target enrollment
48
Study length
about 3.8 years
Ages
18+
Locations
1 site in MN
What this study is about
Researchers are testing if a device called the Sentinel Cerebral Protection System can prevent stroke during atrial fibrillation ablation. The trial also looks at whether cognitive function differs between people who use this device and those who don't.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Undergo Magnetic Resonance Imaging
- 2.Use Sentinel® Cerebral Protection System
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Procedures
imaging
Body systems
Cardiology / Heart